Pharmacologically directed strategies in academic anticancer drug discovery based on the European NCI compounds initiative

por Hendriks, Hans R, Govaerts, Anne-Sophie, Fichtner, Iduna, Burtles, Sally, Westwell, Andrew D, Peters, Godefridus J
Publicado 2017

Pharmacogenomics characterization of the MDM2 inhibitor MI-773 reveals candidate tumours and predictive biomarkers

por Vuaroqueaux, Vincent, Hendriks, Hans R., Al-Hasani, Hoor, Peille, Anne-Lise, Das, Samayita, Fiebig, Heinz-Herbert
Publicado 2021

High In Vitro and In Vivo Activity of BI-847325, a Dual MEK/Aurora Kinase Inhibitor, in Human Solid and Hematologic Cancer Models

por Vuaroqueaux, Vincent, Musch, Alexandra, Peille, Anne-Lise, Kelter, Gerhard, Weichert, Loreen, Metz, Thomas, Hendriks, Hans R., Fiebig, Heinz-Herbert
Publicado 2023

Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models

por Bergman, Andries M., Adema, Auke D., Balzarini, Jan, Bruheim, Skjalg, Fichtner, Iduna, Noordhuis, Paul, Fodstad, Øystein, Myhren, Finn, Sandvold, Marit L., Hendriks, Hans R., Peters, Godefridus J.
Publicado 2010